V. R. Krishnam Raju, Anjali Jha
Abstract
Posaconazole is a triazole-based fluorinated antifungal drug (Figure 1), approved by the US FDA in 2006 and sold under the brand names Noxafil and Posanol.1–4 As with any pharmacologically active i...
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Posaconazole is a triazole-based fluorinated antifungal drug (Figure 1), approved by the US FDA in 2006 and sold under the brand names Noxafil and Posanol.1–4 As with any pharmacologically active i...
Key concepts: Posaconazole, Chemistry, Antifungal, Microbiology, Voriconazole, Biology